Latest Data & Signals Issued

Signal Type Signal Value Data
Score -5.238 1 day ( 0 % )
Last Price $0.472 -10.96 %
High/ Low $0.416 - $0.540 16.82%
Chg 7 Days -6.57 % $0.505 $0.472
Chg 30 Days 60.51 % $0.294 $0.472
Chg 12 mos -37.08 % $0.750 $0.472
Trend - 3 mos 17.52 % Width: 118.82 %
Trend - 12 mos -20.60 % Width: 390.44 %
Pred. range - 3 mos $0.392 - $0.86 -17.02 % - 81.58 %
Pred. range - 12 mos $0.112 - $0.547 -76.35 % - 15.97 %
Short MA avg 3 mos Sell 2024-03-27 - 2 days
Long MA avg 3 mos Sell 2024-03-27 - 2 days
Short/Long MA avg 3 mos Sell 2024-03-19 - 8 days
Short MA avg 12 mos Sell 2024-03-27 - 2 days
Long MA avg 12 mos Buy 2024-02-29 - 21 days
Short/Long MA avg 12 mos Buy 2023-11-22 - 87 days
Pivot Short Buy 2024-03-14 - 11 days
Bollinger Buy 2023-10-30 - 104 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals. NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal... NRXP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT